1Said SM, Sethi S, Valeri AM, e! al. Renal amyloidosis: origin and clini-copathologic correlations of 474 recent cases[ J ]. merican Society of Nephrolo~ : CJASN ,2013,8.
2Real de Asua D, Costa R, Galvan JM, et al. Systemic AA amyloid- osis : epidemiolo~, diagnosis, and management [ J ]. Clinical Epide- miology,2014 ,6 :369 -377.
3Tsai SF, Wen MC, Cheng CH, et al. Clinical features of renal amy- Ioidosis:an analysis of dO patients in a 28-year follow-up [ J 1. Intern Med,2011,50(21 ) :2511 -2517.
5[2]Fishbaugh D F, Wilson S, Preisch J W.Rel ationship of tonsil size on an airway blockage maneuver in children durig sedation[J].Pediat-Dent,1997,19(4):277-281.
6Sambatakou H, Dupont B, Lode H, et al. Vorieonazole treatment for subacute invasive and chronic pulmonary' aspergillosis [J]. Am J Meal,2006,119(6) :527.17-24.
8Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature com- mittee of the International Society of Amyloidosis [ J ]. Amyloid, 2010, 17 : 101 - 104.
9Comenzo RL. How I treat amyloidosis [ J ]. Blood, 2009, 114 (15) : 3147 -3157.
10Ding L, Li W, Wang K, et al. Primary tracheobronehial amyloid- osis in China: analysis of 64 eases and a review of literature[J]. J Huazhong Univ Sei Teehnolog Med Sci, 2010, 30:599 - 603.
